U.S. pharmaceutical consulting market grows 10.4 per cent to $1.7bn
Reigning in prices results in strong growth for consultants
Consultants help Pharma adapt to 'beyond the pill' and post M&A

Pharmaceutical companies - historically one of the most reluctant buyers of consultancy services - became one of the fastest growing users of consultants in the U.S. in 2015 - up 10.4 per cent to $1.7bn. While patent expirations continued at a modest rate, a focus on costs and profitability was high on the agenda - creating a demand for lean manufacturing and laboratory management from consultants.